Oct. 28, 2011
BOSTON — The top story in innovation this week is that Weston-based Biogen Idec met its goals in a second clinical trial of the company's first pill for multiple sclerosis (MS). The neurodegenerative disease affects 400,000 patients in the U.S.; Biogen is the world’s largest MS drugmaker, selling injectable treatments. In the study, Biogen’s pill reduced MS flareups by 44 percent when patients took it twice a day and by 51 percent when they took it three times a day. It’s an important milestone for Biogen, since two of its competitors — Novartis and Acorda Therapeutics — have already gained FDA approval for oral MS treatments.
In other news, Bedford-based iRobot, the maker of Roomba vacuum cleaners and military PackBots, reported a strong third-quarter profit but laid off 8 percent of its staff — a total of 55 workers — across Massachusetts, North Carolina and California.
MassChallenge, the Boston startup accelerator and business competition, awarded $1 million in prizes among 17 startups. Alkeus Pharmaceuticals, Sanergy and Tinfoil Security led the way with $100,000 each.
More broadly, Bay State companies raised $250 million in venture capital last month. The total for the third quarter was $505 million, down by about half from the previous quarter, when there was talk of a new tech bubble.
The weekly roundup of business, technology and life science news from our partners at Xconomy.com airs every Friday on WGBH 89.7 Boston Public Radio.
Comment on This Article
From The World's Science podcast to Nova, we'll deliver updates from these cutting edge programs. See a sample »